Key points are not available for this paper at this time.
89Zr-pembrolizumab uptake in tumor lesions correlated with treatment response and patient survival. 89Zr-pembrolizumab also showed uptake in lymphoid tissues and at sites of inflammation.
Kok et al. (Mon,) studied this question.